Brief: Zealand Scraps Potential Obesity Drug, Citing Crowded Market - Bloomberg News
Nov 13 (Reuters) - Zealand Pharma A/S ZELA.CO: ZEALAND SCRAPS POTENTIAL OBESITY DRUG, CITING CROWDED MARKET - BLOOMBERG NEWS Source text: https://tinyurl.com/3uzmvhe3 Further company coverage: ZELA.CO ((Reuters.briefs@thomsonreuters.com;))
Recent news on Zealand Pharma A/S
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Zealand Pharma Announces Positive Topline Results From Phase 1 Trial With ZP9830
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Zealand Pharma, Generate Biomedicines Enter Collaboration, License Agreement
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion (updated)